Precigen, Inc. (PGEN) stock forecast and price target
Price $4.54 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($4.54)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $0.24 | — | $240M |
| Next fiscal year ends December 31, 2027 | $0.62 | — | $442M |
| Next quarter ends December 31, 2026 | $0.11 | — | $88M |
| Quarter after ends March 31, 2027 | $0.14 | — | $93M |
Consensus of the analysts covering Precigen, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 201.0% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Precigen’s intrinsic value about 88% below today’s market value, and it scores 0.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Precigen stock price target?
The average 12-month target from 3 analysts is $13.67, 201.0% above the current price of $4.54 Targets range from $11.00 to $18.00.
Is Precigen a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 2 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Precigen expected to earn?
Analysts expect EPS of $0.24 for the fiscal year ending December 31, 2026 and $0.62 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.